Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.
Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Hepatology. 2023 Aug 1;78(2):503-517. doi: 10.1097/HEP.0000000000000373. Epub 2023 Apr 1.
The aim of the study was to investigate the role and mechanisms of tuberous sclerosis complex 1 (TSC1) and mechanistic target of rapamycin complex 1 (mTORC1) in alcohol-associated liver disease.
Liver-specific Tsc1 knockout (L- Tsc1 KO) mice and their matched wild-type mice were subjected to Gao-binge alcohol. Human alcoholic hepatitis (AH) samples were also used for immunohistochemistry staining, western blot, and quantitative real-time PCR (q-PCR) analysis. Human AH and Gao-binge alcohol-fed mice had decreased hepatic TSC1 and increased mTORC1 activation. Gao-binge alcohol markedly increased liver/body weight ratio and serum alanine aminotransferase levels in L- Tsc1 KO mice compared with Gao-binge alcohol-fed wild-type mice. Results from immunohistochemistry staining, western blot, and q-PCR analysis revealed that human AH and Gao-binge alcohol-fed L- Tsc1 KO mouse livers had significantly increased hepatic progenitor cells, macrophages, and neutrophils but decreased HNF4α-positive cells. Gao-binge alcohol-fed L- Tsc1 KO mice also developed severe inflammation and liver fibrosis. Deleting Tsc1 in cholangiocytes but not in hepatocytes promoted cholangiocyte proliferation and aggravated alcohol-induced ductular reactions, fibrosis, inflammation, and liver injury. Pharmacological inhibition of mTORC1 partially reversed hepatomegaly, ductular reaction, fibrosis, inflammatory cell infiltration, and liver injury in alcohol-fed L- Tsc1 KO mice.
Our findings indicate that persistent activation of mTORC1 due to the loss of cholangiocyte TSC1 promotes liver cell repopulation, ductular reaction, inflammation, fibrosis, and liver injury in Gao-binge alcohol-fed L- Tsc1 KO mice, which phenocopy the pathogenesis of human AH.
本研究旨在探讨结节性硬化复合物 1(TSC1)和雷帕霉素靶蛋白复合物 1(mTORC1)在酒精相关性肝病中的作用及其机制。
采用肝特异性敲除 Tsc1(L- Tsc1 KO)小鼠及其同窝野生型小鼠进行高剂量酒精灌胃。同时,还对人酒精性肝炎(AH)样本进行免疫组化染色、Western blot 和实时定量 PCR(q-PCR)分析。结果显示,人 AH 和高剂量酒精灌胃的小鼠肝组织 TSC1 减少,mTORC1 激活增加。与高剂量酒精灌胃的野生型小鼠相比,高剂量酒精显著增加了 L- Tsc1 KO 小鼠的肝/体重比和血清丙氨酸氨基转移酶水平。免疫组化染色、Western blot 和 q-PCR 分析结果显示,人 AH 和高剂量酒精灌胃的 L- Tsc1 KO 小鼠肝组织中肝祖细胞、巨噬细胞和中性粒细胞显著增加,而 HNF4α阳性细胞减少。高剂量酒精灌胃的 L- Tsc1 KO 小鼠也发生了严重的炎症和肝纤维化。在胆管细胞中而非肝细胞中敲除 Tsc1 可促进胆管细胞增殖,并加重酒精诱导的胆管反应、纤维化、炎症和肝损伤。mTORC1 的药理学抑制部分逆转了酒精灌胃的 L- Tsc1 KO 小鼠的肝肿大、胆管反应、纤维化、炎症细胞浸润和肝损伤。
我们的研究结果表明,由于胆管细胞 TSC1 的缺失导致 mTORC1 的持续激活,促进了酒精灌胃的 L- Tsc1 KO 小鼠的肝细胞再增殖、胆管反应、炎症、纤维化和肝损伤,其表型类似于人类 AH 的发病机制。